NxStage Launches 3rd Annual Nurse Hero Contest to Celebrate Home Hemodialysis Nurses
LAWRENCE, Mass., June 15, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today launched its 3rd annual Nurse Hero contest to honor the critical role home hemodialysis nurses play in educating, training and supporting NxStage®System One™ patients. NxStage is accepting nominations for the award online at www.NxStageNurseHero.com through the end of June. Voting will occur from July 10th to August 2nd, and the winner will be announced in September.
"I was truly honored to receive NxStage's 'Nurse Hero' award," said Joy Barringer, 2016 Nurse Hero Award winner from Satellite Healthcare, Memphis TN. "It speaks not only to my commitment to providing patients with the highest quality of care, but also to the passion and dedication of all the home hemodialysis training nurses and our commitment to get patients home."
"Our Nurse Hero contest gives patients and healthcare professionals an opportunity to celebrate the nurses that make a difference in their lives," said Joe Turk, president of NxStage Medical, Inc. "Home hemodialysis nurses are champions of patient choice and access to home therapy options."
To learn more about NxStage's Nurse Hero contest, visit www.NxStageNurseHero.com and join the conversation on Facebook at www.facebook.com/NxStage and Twitter at @NxStage.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared specifically by the FDA for home hemodialysis and home nocturnal hemodialysis. The simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow™ SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on-site on-demand. Unlike conventional hemodialysis systems, the System One family of products requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping - at home or on vacation and at a medically appropriate treatment frequency. In addition, NxStage's Nx2me Connected Health® platform collects important NxStage System One and patient information for flexible viewing, monitoring and reporting that may improve patient management and patient retention, as well as simplify alternative site care. The System One is also used to provide a range of flexible therapy options in more traditional care settings such as hospitals and dialysis centers. Its safety and performance have been demonstrated by experience with more than 14 million treatments with over 30 thousand patients around the world. www.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD. For more information on NxStage and its products and services, please visit the Company's websites at nxstage.com and nxstagekidneycare.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Media contact:
Kristen K. Sheppard, Esq.
[email protected]
SOURCE NxStage Medical, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article